fda semaglutide warning news october 2025 The has approved the first GLP-1 pill for weight loss, a milestone in the growth of the revolutionary drugs. The drug, a once-a-day Wegovy tablet, is also approved for reducing cardiovascular US FDA warns online vendors

Kapiglucagon is a proprietary glucagon prodrug being developed for type 1 diabetes, a precursor compound designed to overcome the physical and chemical limitations of native glucagon

At-home kits are available but cost significantly more and are less accurate

If a person has one or two drinks and has minor side effects, such as increased dizziness or nausea, these effects typically go away within a few hours, once the effects of the alcohol wear off

Patients considering GLP-1 therapy should inform their endocrinologist or primary care provider, as thyroid function monitoring may need to be intensified during periods of significant weight loss